2016
2015
2016
2017
2018
2019
2020
Solas BioVentures to Seek Up to $100M for Second Early-Stage Fund
SEPT 2, 2016
Learn More
Drug Developer Arrivo BioVentures Launches With $49M
MAY 25, 2016
Learn More
CardioNXT Secures Additional $1.5M Funding From Solas BioVentures To Drive Atrial Fibrillation Treatment Innovation
MAY 24, 2016
Learn More
HOME
TEAM
PORTFOLIO
ABOUT
NEWS
More...